What medication is appropriate for maintaining sleep in patients with sleep maintenance insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medication for Sleep Maintenance Insomnia

For sleep maintenance insomnia specifically, use suvorexant or doxepin as first-line pharmacologic options, with eszopiclone or zolpidem as alternatives. 1

Primary Recommendations for Sleep Maintenance

The American Academy of Sleep Medicine (AASM) 2017 guideline provides the most authoritative framework for medication selection in sleep maintenance insomnia 1:

First-Tier Options:

  • Suvorexant (dual orexin receptor antagonist) - specifically recommended for sleep maintenance insomnia 1
  • Doxepin (low-dose) - specifically recommended for sleep maintenance insomnia 1
  • Eszopiclone - effective for both sleep onset AND maintenance 1
  • Zolpidem - effective for both sleep onset AND maintenance 1

Second-Tier Option:

  • Temazepam - covers both sleep onset and maintenance 1

Evidence Quality and Practical Considerations

While all these recommendations carry "WEAK" strength ratings in the AASM guideline, this reflects GRADE methodology limitations (small trials, industry funding, heterogeneity) rather than lack of clinical utility 1. The American College of Physicians found that eszopiclone, zolpidem, and suvorexant improved sleep outcomes with low-to-moderate strength evidence, though absolute effect sizes were small 2.

Recent research supports specific agents:

  • Zolpidem improved all objective sleep parameters including wake after sleep onset (WASO) in young and middle-aged adults, though it carries drowsiness risk 3
  • Daridorexant (newer orexin antagonist) specifically reduced WASO and increased total sleep time 3
  • Dual orexin receptor antagonists are particularly effective for sleep maintenance problems 4

Critical Safety Warnings

Avoid these medications despite common off-label use:

  • Trazodone - explicitly NOT recommended by AASM despite being the most commonly prescribed off-label agent 1, 5
  • Antihistamines (diphenhydramine) - not recommended 1
  • Melatonin - not recommended for sleep maintenance 1
  • Benzodiazepines - associated with dementia, fractures, major injury, cognitive impairment, and driving impairment 2

Algorithm for Selection

Step 1: Confirm sleep maintenance insomnia (difficulty staying asleep, frequent awakenings, early morning awakening)

Step 2: Choose based on patient factors:

  • If cognitive impairment concerns or older adult: Suvorexant or low-dose doxepin (avoid Z-drugs) 5, 6
  • If comorbid depression/anxiety: Eszopiclone or zolpidem are safe options 5
  • If respiratory impairment: Avoid Z-drugs; consider suvorexant 5
  • If younger/middle-aged without comorbidities: Any first-tier option acceptable

Step 3: Dose at lowest effective level for shortest duration (ideally <6 weeks or as-needed basis) 5, 7

Step 4: Always combine with cognitive behavioral therapy for insomnia (CBT-I) as the evidence-based first-line treatment 1

Common Pitfalls

  • Using trazodone because it's "commonly prescribed" - this lacks evidence and is explicitly not recommended 1
  • Chronic nightly use - pharmacotherapy should be time-limited or as-needed 5
  • Prescribing without addressing sleep hygiene and CBT-I - medications alone are insufficient 1
  • Using benzodiazepines in older adults - high risk of falls, fractures, and cognitive decline 2
  • Assuming melatonin works for maintenance insomnia - evidence does not support this 1

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Research

Treatment of Chronic Insomnia in Adults.

American family physician, 2024

Research

Insomnia in ambulatory care: A clinical review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.